These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37667412)

  • 21. Symptomatic Profile and Cognitive Performance in Autopsy-Confirmed Limbic-Predominant Age-Related TDP-43 Encephalopathy With Comorbid Alzheimer Disease.
    Gauthreaux K; Mock C; Teylan MA; Culhane JE; Chen YC; Chan KCG; Katsumata Y; Nelson PT; Kukull WA
    J Neuropathol Exp Neurol; 2022 Nov; 81(12):975-987. PubMed ID: 36264254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TAR DNA-Binding Protein 43 Is Associated with Rate of Memory, Functional and Global Cognitive Decline in the Decade Prior to Death.
    Buciuc M; Tosakulwong N; Machulda MM; Whitwell JL; Weigand SD; Murray ME; Reichard RR; Parisi JE; Dickson DW; Boeve BF; Knopman DS; Petersen RC; Josephs KA
    J Alzheimers Dis; 2021; 80(2):683-693. PubMed ID: 33579840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between APOE-ε4 allele and cognitive function is mediated by Alzheimer's disease pathology: a population-based autopsy study in an admixed sample.
    Paradela RS; Justo AFO; Paes VR; Leite REP; Pasqualucci CA; Grinberg LT; Naslavsky MS; Zatz M; Nitrini R; Jacob-Filho W; Suemoto CK
    Acta Neuropathol Commun; 2023 Dec; 11(1):205. PubMed ID: 38115150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive and Neuropsychological Profiles in Alzheimer's Disease and Primary Age-Related Tauopathy and the Influence of Comorbid Neuropathologies.
    Walker JM; Gonzales MM; Goette W; Farrell K; White Iii CL; Crary JF; Richardson TE
    J Alzheimers Dis; 2023; 92(3):1037-1049. PubMed ID: 36847012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuropathologic Changes of Alzheimer's Disease and Related Dementias: Relevance to Future Prevention.
    White LR; Corrada MM; Kawas CH; Cholerton BA; Edland SE; Flanagan ME; Montine TJ
    J Alzheimers Dis; 2023; 95(1):307-316. PubMed ID: 37522210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive symptoms progress with limbic-predominant age-related TDP-43 encephalopathy stage and co-occurrence with Alzheimer disease.
    Hiya S; Maldonado-Díaz C; Walker JM; Richardson TE
    J Neuropathol Exp Neurol; 2023 Dec; 83(1):2-10. PubMed ID: 37966908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The vascular risk factors and vascular neuropathology in subjects with autopsy-confirmed dementia with Lewy bodies.
    Chen ZC; Gan J; Yang Y; Meng Q; Han J; Ji Y
    Int J Geriatr Psychiatry; 2022 Mar; 37(3):. PubMed ID: 35128731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia.
    James BD; Wilson RS; Boyle PA; Trojanowski JQ; Bennett DA; Schneider JA
    Brain; 2016 Nov; 139(11):2983-2993. PubMed ID: 27694152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuropsychiatric symptoms in limbic-predominant age-related TDP-43 encephalopathy and Alzheimer's disease.
    Liu KY; Reeves S; McAleese KE; Attems J; Francis P; Thomas A; Howard R
    Brain; 2020 Dec; 143(12):3842-3849. PubMed ID: 33188391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study.
    Fotiadis P; van Rooden S; van der Grond J; Schultz A; Martinez-Ramirez S; Auriel E; Reijmer Y; van Opstal AM; Ayres A; Schwab KM; ; Hedden T; Rosand J; Viswanathan A; Wermer M; Terwindt G; Sperling RA; Polimeni JR; Johnson KA; van Buchem MA; Greenberg SM; Gurol ME
    Lancet Neurol; 2016 Jul; 15(8):811-819. PubMed ID: 27180034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lewy- and Alzheimer-type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum.
    Sierra M; Gelpi E; Martí MJ; Compta Y
    Neuropathol Appl Neurobiol; 2016 Aug; 42(5):451-62. PubMed ID: 26810462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are there morphological differences between Parkinson's disease-dementia and dementia with Lewy bodies?
    Jellinger KA
    Parkinsonism Relat Disord; 2022 Jul; 100():24-32. PubMed ID: 35691178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resistance and resilience to Alzheimer's disease pathology are associated with reduced cortical pTau and absence of limbic-predominant age-related TDP-43 encephalopathy in a community-based cohort.
    Latimer CS; Burke BT; Liachko NF; Currey HN; Kilgore MD; Gibbons LE; Henriksen J; Darvas M; Domoto-Reilly K; Jayadev S; Grabowski TJ; Crane PK; Larson EB; Kraemer BC; Bird TD; Keene CD
    Acta Neuropathol Commun; 2019 Jun; 7(1):91. PubMed ID: 31174609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Morphological characteristics differentiate dementia with Lewy bodies from Parkinson disease with and without dementia.
    Jellinger KA
    J Neural Transm (Vienna); 2023 Jul; 130(7):891-904. PubMed ID: 37306790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LATE-NC aggravates GVD-mediated necroptosis in Alzheimer's disease.
    Koper MJ; Tomé SO; Gawor K; Belet A; Van Schoor E; Schaeverbeke J; Vandenberghe R; Vandenbulcke M; Ghebremedhin E; Otto M; von Arnim CAF; Balusu S; Blaschko MB; De Strooper B; Thal DR
    Acta Neuropathol Commun; 2022 Sep; 10(1):128. PubMed ID: 36057624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel clinicopathological characteristics differentiate dementia with Lewy bodies from Parkinson's disease dementia.
    Hansen D; Ling H; Lashley T; Foley JA; Strand C; Eid TM; Holton JL; Warner TT
    Neuropathol Appl Neurobiol; 2021 Feb; 47(1):143-156. PubMed ID: 32720329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal-dominant Alzheimer's disease.
    Carmona-Iragui M; Balasa M; Benejam B; Alcolea D; Fernández S; Videla L; Sala I; Sánchez-Saudinós MB; Morenas-Rodriguez E; Ribosa-Nogué R; Illán-Gala I; Gonzalez-Ortiz S; Clarimón J; Schmitt F; Powell DK; Bosch B; Lladó A; Rafii MS; Head E; Molinuevo JL; Blesa R; Videla S; Lleó A; Sánchez-Valle R; Fortea J
    Alzheimers Dement; 2017 Nov; 13(11):1251-1260. PubMed ID: 28463681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ageing-Related Neurodegeneration and Cognitive Decline.
    Alafuzoff I; Libard S
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Capillary cerebral amyloid angiopathy in Alzheimer's disease: association with allocortical/hippocampal microinfarcts and cognitive decline.
    Hecht M; Krämer LM; von Arnim CAF; Otto M; Thal DR
    Acta Neuropathol; 2018 May; 135(5):681-694. PubMed ID: 29574591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mixed neuropathologies and associations with domain-specific cognitive decline.
    Brenowitz WD; Hubbard RA; Keene CD; Hawes SE; Longstreth WT; Woltjer RL; Kukull WA
    Neurology; 2017 Oct; 89(17):1773-1781. PubMed ID: 28939667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.